Fernando Walder

Fernando Walder

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ATAlfio Tincani
Alfio Tincani
CLCarlos Lehn
Carlos Lehn
CCCláudio Cernea
Cláudio Cernea
EQEmilson Queiroz
Emilson Queiroz
FDFernando Luiz Dias
Fernando Luiz Dias
SVSylvio Vasconcellos
Sylvio Vasconcellos
When analyzing the literature published on thyroidectomy using a “timeline” we can observe that we have notoriously progressed from a procedure that was almost prohibited in the mid-nineteenth century due to complications to a point where it is considered safe, resolutive, and highly efficient. This progress is especially due to the advances in surgical techniques. Theodore Kocher (Nobel Prize in 1909 for his contribution to thyroidectomies) flawlessly described the anatomical basis for the success of this surgical technique 130 years ago. Besides this, advances in anesthetic procedures, surgical materials, and medications were fundamental to intraoperative and postoperative advances and patient management. With time, the knowledge on the different thyroid diseases has exponentially increased and serves as indicators for the extension of treatment and surgical procedures, all efforts should be directed to apply them into clinical practice (1 1. Cernea CR, Brandão LG, Hojaij FC, De Carlucci D, Montenegro FL, Plopper C, et al. How to minimize complications in thyroid surgery? Auris Nasus Larynx. 2010;37(1):1-5. ).

24 November 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ATAlfio Tincani
Alfio Tincani
CLCarlos Lehn
Carlos Lehn
CCCláudio Cernea
Cláudio Cernea
EQEmilson Queiroz
Emilson Queiroz
FDFernando Luiz Dias
Fernando Luiz Dias
SVSylvio Vasconcellos
Sylvio Vasconcellos
Dear Editors and Colleagues We have examined with attention the comments of the letter to the Editor in regards to our recently published article (), and want to thank its authors for their interest in our work. […] Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers’s Point of View Dear Editors and Colleagues We have examined with attention the comments of the letter to the Editor in regards to our recently published article (), and want to thank its authors for their interest in our work. […] Response to the letter: Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Pioneers’s Point of View

27 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
GMGiulianno Molina Melo
Giulianno Molina Melo
MNMurilo Catafesta Neves
Murilo Catafesta Neves
RRRafael Dias Romero
Rafael Dias Romero
MRMarcello Rosano
Marcello Rosano
RMRodrigo Tadashi Martines
Rodrigo Tadashi Martines
OCOnivaldo Cervantes
Onivaldo Cervantes
Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing CSCC is 65–250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases, and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LACSCC) of the head and neck region in transplant patients. Methods: 16-year retrospective, single-center series of patients with LACSCC in the head and neck region who underwent surgical treatment. Clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence, and survival were analyzed. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. The most affected regions were malar/nasal (28.8%) and auricular (19.2%). Surgeries included wide resection with reconstruction (58.9%), exenteration (14.1%), and temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p = 0.009), transplanted (p = 0.006), compromised margin (p = 0.049); Mortality: immunosuppression (p = 0.028), total resection and reconstruction (p = 0.013), stage (8ed) III-IV (p < 0.001), compromised margin (p < 0.001), neck metastasis with extranodal extension (p = 0.018). Multivariate analysis: Recurrence: transplanted HR: 3.69 (p < 0.001), neck metastasis extranodal extension HR: 5.41 (p < 0.001), evolution to distant metastasis HR: 5.27 (p < 0.001); Mortality: neck metastasis extranodal extension HR: 1.94, (p = 0.032), compromised margins HR: 1.87 (p = 0.001). Main surgical procedures: temporalectomy HR: 2.83 (p = 0.007), major rhinectomy HR: 2.47 (p = 0.005); Worst overall survival: Tx compared to NonTx (p = 0.069); Worst survival with recurrence: Tx compared to NonTx (p = 0.005). Conclusions: The LACSCC and transplanted (immunosuppressed) group present low survival, worse prognosis; The formulation of specific guidelines to standardize treatment and predict outcomes on this population are strictly necessary.

23 October 2021 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
GMGiulianno Molina Melo
Giulianno Molina Melo
AGAntonio José Gonçalves
Antonio José Gonçalves
FWFernando Walder
Fernando Walder
CFCarolina Ferraz
Carolina Ferraz
MNMurilo Catafesta Neves
Murilo Catafesta Neves
OCOnivaldo Cervantes
Onivaldo Cervantes
Goiters and benign nodules detected in the thyroid are growing lesions and the COVID-19 pandemic have negatively impacted on their surgical treatment. The appropriate selection of patients to treatment will improve the overall health status. This article review will focus on the impact of the COVID-19 pandemic on treatment of benign conditions of the thyroid gland and their implications. This review pointed out the status of the health system in developing country and the problems to treat benign surgical diseases of thyroid. Aspects of epidemiology, incidence, clinical presentation and surgical treatment of goiters, economic and health status impact were cited. All surgical treatment of goiter and other benign conditions were postponed, forced to redirect, and reschedule all benign surgeries, situation aggravated by poor public management and closure of hospital beds. These conditions have caused deterioration in patients’ physical (decompensated thyroid disease) and mental health status, increasing work disabilities and burdening society by increasing the social and health cost. The overall situation could be catastrophic in emergent countries where this increased disease-related social expenditure on surgical treatment may increase the risk of national impoverishment as increase the treatment cost. Brazilian Society Head and Neck Surgery related some recommendations and new suggestions were made to safely treat these high potential hazard surgical conditions. Surgeries for goiter and benign thyroid conditions can be performed during the COVID-19 pandemic, following strict safety protocols for the patient and the medical team, reducing the negative economic and on patient health impact.

1 November 2022 in Brazilian Journal of Otorhinolaryngology (Versão em Português)
Verified
Journal Article
Closed access
GMGiulianno Molina Melo
Giulianno Molina Melo
AGAntonio José Gonçalves
Antonio José Gonçalves
FWFernando Walder
Fernando Walder
CFCarolina Ferraz
Carolina Ferraz
MNMurilo Catafesta Neves
Murilo Catafesta Neves
OCOnivaldo Cervantes
Onivaldo Cervantes

10 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GMGiulianno Molina Melo
Giulianno Molina Melo
MNMurilo Catafesta Neves
Murilo Catafesta Neves
RRRafael Dias Romero
Rafael Dias Romero
MRMarcello Rosano
Marcello Rosano
RMRodrigo Tadashi Martines
Rodrigo Tadashi Martines
OCOnivaldo Cervantes
Onivaldo Cervantes
Background: Squamous cell carcinoma of the skin (SCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing SCC is 65-250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LASCC) of the head and neck region in transplant patients. Methods:16-year retrospective, single-center series of patients with LASCC in the head and neck region who underwent surgical treatment. Were analyzed: clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence and survival. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. Most affected regions: malar/nasal (28.8%), auricular (19.2%). Surgeries: wide resection with reconstruction (58.9%), exenteration (14.1%), temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p=0.009), transplanted (p=0.006), compromised margin (p=0.049), Mortality: immunosuppression (p=0.028), Total Resection and reconstruction (p=0.013), Stage(8ed) III-IV (p<0.001), compromised margin (p<0.001), neck metastasis with extranodal extension (p=0.018). Multivariate analysis: Recurrence: Transplanted HR:3.69 (p<0.001), Neck metastasis extranodal extension HR:5.41 (p<0.001), Evolution to Distant metastasis HR:5.27 (p<0.001); Mortality: Neck metastasis extranodal extension HR:1.94, (p=0.032), Compromised Margins HR:1.87 (p=0.001), Main Surgical Procedures: Temporalectomy HR:2.83 (p=0.007); Major Rhinectomy HR:2.47 (p=0.005); Worst Overall Survival: Tx compared to NonTx (p=0.069), Worst Survival with Recurrence: Tx compared to NonTx (p=0.005). Conclusions: The LASCC and Transplanted (immunosuppressed) group present low survival, worse prognosis, high risk of recurrence and mortality outcome, formulation of specific guidelines to standardize treatment and predict outcomes in this population are strictly necessary.